722 related articles for article (PubMed ID: 17513820)
1. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
Hudis CA; Barlow WE; Costantino JP; Gray RJ; Pritchard KI; Chapman JA; Sparano JA; Hunsberger S; Enos RA; Gelber RD; Zujewski JA
J Clin Oncol; 2007 May; 25(15):2127-32. PubMed ID: 17513820
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
Freeman AB; Huang B; Dragun AE
Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
[TBL] [Abstract][Full Text] [Related]
3. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
[TBL] [Abstract][Full Text] [Related]
5. [1st revision of the National Consensus on Breast Cancer Treatment].
Consenso Nacional sobre Tratamiento del Cáncer Mamario
Ginecol Obstet Mex; 2002 Jul; 70():349-60. PubMed ID: 12221911
[No Abstract] [Full Text] [Related]
6. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer: non-metastatic.
Dixon JM; Gregory K; Johnston S; Rodger A
Clin Evid; 2002 Jun; (7):1603-30. PubMed ID: 12230775
[No Abstract] [Full Text] [Related]
8. Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?
Schnitt SJ
Am J Clin Pathol; 2003 Oct; 120(4):485-8. PubMed ID: 14560560
[No Abstract] [Full Text] [Related]
9. NCCN: Breast cancer.
Carlson RW; Edge SB; Theriault RL;
Cancer Control; 2001; 8(6 Suppl 2):54-61. PubMed ID: 11760559
[TBL] [Abstract][Full Text] [Related]
10. Controversies in design and interpretation of adjuvant clinical trials.
Cuzick J
Cancer Invest; 2010; 28 Suppl 1():28-34. PubMed ID: 20653405
[TBL] [Abstract][Full Text] [Related]
11. Palliative approaches to the patient with breast cancer.
Bartus CM; Schreiber JS; Kurtzman SH
Surg Oncol Clin N Am; 2004 Jul; 13(3):517-30, ix. PubMed ID: 15236733
[TBL] [Abstract][Full Text] [Related]
12. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Tang SC
Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
[TBL] [Abstract][Full Text] [Related]
13. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
Le Tourneau C; Michiels S; Gan HK; Siu LL
J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
[TBL] [Abstract][Full Text] [Related]
14. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
Solin LJ
J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
[No Abstract] [Full Text] [Related]
15. Early-stage breast cancer rates rise sharply as invasive breast cancer levels off.
Oncology (Williston Park); 2005 Aug; 19(9):1176. PubMed ID: 16404785
[No Abstract] [Full Text] [Related]
16. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision.
Güth U; Huang DJ; Dirnhofer S; Rochlitz C; Wight E
Cancer J; 2009; 15(1):81-6. PubMed ID: 19197181
[TBL] [Abstract][Full Text] [Related]
17. [Breast cancer treatment].
Duodecim; 2005; 121(3):317-8. PubMed ID: 15787290
[No Abstract] [Full Text] [Related]
18. Breast cancer: non-metastatic.
Dixon JM; Gregory K; Johnston S; Rodger A
Clin Evid; 2002 Dec; (8):1811-39. PubMed ID: 12603971
[No Abstract] [Full Text] [Related]
19. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
Katz A; Smith BL; Golshan M; Niemierko A; Kobayashi W; Raad RA; Kelada A; Rizk L; Wong JS; Bellon JR; Gadd M; Specht M; Taghian AG
J Clin Oncol; 2008 May; 26(13):2093-8. PubMed ID: 18445838
[TBL] [Abstract][Full Text] [Related]
20. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]